Redox regulation of S-nitrosocysteine-mediated vasodilation in vivo

Eur J Pharmacol. 2000 Nov 17;408(2):195-8. doi: 10.1016/s0014-2999(00)00779-2.

Abstract

This study examined the effects of the lipophobic electron acceptor, nitroblue tetrazolium (2x5 micromol/kg, i.v.) on the vasodilation produced by the putative endothelium-derived S-nitrosothiol, L-S-nitrosocysteine (400 nmol/kg, i.v.), and the nitric oxide (NO) donor, (Z)-1-N-methyl-N-[6(N-methylammoniohexyl)amino]&z. sfnc;diazen-1-ium-1,2-diolate (MAHMA NONOate, 25 nmol/kg, i.v.), in anesthetized rats. The administration of nitroblue tetrazolium resulted in delayed but long-lasting increases in vascular resistances. The L-S-nitrosocysteine-induced vasodilator responses were markedly diminished whereas the MAHMA NONOate-induced responses were not affected by nitroblue tetrazolium. These results support the possibility that L-S-nitrosocysteine interacts with membrane thiols that are subject to nitroblue tetrazolium-induced oxidation (i.e., disulfide-bridge formation) and that nitroblue tetrazolium-induced vasoconstriction may involve a loss of potency of endothelium-derived S-nitrosothiols.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Cysteine / analogs & derivatives*
  • Cysteine / pharmacology
  • Hemodynamics / drug effects
  • Hemodynamics / physiology
  • Indicators and Reagents / pharmacology*
  • Male
  • Nitroblue Tetrazolium / pharmacology*
  • Nitroprusside / pharmacology
  • Nitroso Compounds / pharmacology*
  • Oxidation-Reduction
  • Rats
  • Rats, Sprague-Dawley
  • S-Nitrosothiols*
  • Vasodilation / drug effects*
  • Vasodilation / physiology
  • Vasodilator Agents / pharmacology*

Substances

  • Indicators and Reagents
  • Nitroso Compounds
  • S-Nitrosothiols
  • Vasodilator Agents
  • Nitroprusside
  • Nitroblue Tetrazolium
  • S-nitrosocysteine
  • Cysteine